Verve Therapeutics Inc (VERV)

33.15 -2.59  -7.25% NASDAQ Nov 26, 16:00 USD

Verve Therapeutics Net Income (TTM):

-112.51M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Net Income (TTM) Chart

Export Data
Save Image
Print Image

Historical Net Income (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 -112.51M
June 30, 2021 -98.75M
March 31, 2021 -53.36M
Dec. 31, 2020 -45.70M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Net Income Definition

Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.

Read full definition.

Net Income (TTM) Benchmarks

Regenxbio Inc -212.42M
Krystal Biotech Inc -58.15M
Beam Therapeutics Inc -401.40M

Net Income (TTM) Range, Past 5 Years

Minimum -112.51M Sep 2021
Maximum -45.70M Dec 2020
Average -77.58M


Verve Therapeutics' Q3 Net Loss Shrinks
MT Newswires 11/10 07:51 ET
Top IPO additions to Russell 2000 Index
SA Breaking News 09/17 10:48 ET
WHO urges fair access to gene-editing technologies
SA Breaking News 07/12 11:51 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.